SCHEMBL5010938

SCHEMBL5010938

O=C(O)c1ccc2c(c1)C(=O)N(Cc1ccccc1Cl)C2=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.72
HPGD P15428 2/20 0.72
MEN1 O00255 2/20 0.72
CACNA1G O43497 4/20 0.60
ENPP2 Q13822 1/20 0.59
POLB P06746 3/20 0.57
CA1 P00915 2/20 0.55
CA4 P22748 2/20 0.55
CA9 Q16790 2/20 0.55
CA2 P00918 1/20 0.55
ALDH1A1 P00352 1/20 0.51
CA12 O43570 1/20 0.51
CA7 P43166 1/20 0.51
PKM P14618 1/20 0.51
MAPK1 P28482 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013737 0.89 CACNA1G (0.60) KMT2AHPGDMEN1CACNA1GENPP2
SCHEMBL12700245 0.86 KMT2A (0.72) KMT2AHPGDMEN1ENPP2POLB
SCHEMBL18669069 0.85 KMT2A (0.70) KMT2AHPGDMEN1ENPP2POLB
SCHEMBL5010573 0.84 KMT2A (1.00) KMT2AHPGDMEN1ENPP2POLB
SCHEMBL5010936 0.84 KMT2A (0.68) KMT2AHPGDMEN1CACNA1GENPP2
SCHEMBL5010059 0.84 KMT2A (0.68) KMT2AHPGDMEN1CACNA1GENPP2
SCHEMBL20010530 0.81 KMT2A (0.88) KMT2AHPGDMEN1ENPP2POLB
SCHEMBL10339317 0.81 TYR (0.64) KMT2AHPGDMEN1CACNA1GPOLB
SCHEMBL5010540 0.81 KMT2A (0.64) KMT2AHPGDMEN1ENPP2POLB
SCHEMBL4239479 0.80 ENPP2 (0.88) KMT2AHPGDMEN1ENPP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319098-B2 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-01-15 US disclosed
US-20070259867-A1 1,3-DIOXOISOINDOLE DERIVATIVES HAVING SELECTIVE ANTAGONISM OF T-TYPE CALCIUM CHANNEL KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259867-A1 1,3-DIOXOISOINDOLE DERIVATIVES HAVING SELECTIVE ANTAGONISM OF T-TYPE CALCIUM CHANNEL CACNA1I, CACNA1G, CACNA1H KMT2A 4804/4885HPGD 1902/4885MEN1 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.